  |  |  |  |
Investments
Novogen stock trades on both the Australian Stock Exchange and the NASDAQ exchange in the USA.
Current prices:
ASX (NRT)
NASDAQ (NVGN)
|
| 
|
|  |
| | | |
Note
To view PDF documents, you will need to have Adobe Acrobat installed.
Click here to download Acrobat from the Adobe website.
|
|
|
| |
 |
Analysts reports
Analyst reports appearing here are the views of the analysts and not necessarily the view of the Company. No Company endorsement is to be implied from this publication or presentation.
| Analyst report for Novogen's subsidiary, Marshall Edwards, Inc. | 11 February, 2008 |
Analyst Brian D Rye, CFA
Download pdf file
|
| Intersuisse - Investment Research- phenoxodiol in phase III clinical trials | 22 October, 2007 |
Analyst: Darren J Grubb PhD MBA
Download pdf file
|
| Aegis Equities Research Pty Ltd - Block-buster drug potential remains | 01 August, 2003 |
Download pdf file
|
| Foster Stockbroking - Approval to treat cervical cancer | 19 June, 2003 |
Analyst: Lawrence Gozlan Ph. (612) 9221 8711 lawrence.gozlan@fostock.com.au
Download pdf file
|
| Foster Stockbroking - Positive results from ASCO | 11 June, 2003 |
Analyst: Lawrence Gozlan Ph. (612) 9221 8711 lawrence.gozlan@fostock.com.au
Download pdf file
|
| Foster Stockbroking - PHENOXODIOL IS PHENOMONAL | 18 October, 2002 |
Analyst: Lawrence Gozlan
Ph. (612) 9221 8711
lawrence.gozlan@fostock.com.au
Download pdf file
|
|
|
|
